Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Biocept, Inc. (BIOCQ) had Debt to Capital Ratio of 0.12 for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$25.86M |
|
$-32.09M |
|
$28.44M |
|
$-2.58M |
|
$57.84M |
|
$-31.98M |
|
$-0.23M |
|
$-32.21M |
|
$-32.21M |
|
$-32.09M |
|
$-32.09M |
|
$-32.09M |
|
$-32.09M |
|
$-31.98M |
|
$-30.33M |
|
0.56M |
|
0.56M |
|
$-56.76 |
|
$-56.76 |
|
| Balance Sheet Financials | |
$16.34M |
|
$2.57M |
|
$14.53M |
|
$30.87M |
|
$5.51M |
|
$1.20M |
|
$16.51M |
|
$22.01M |
|
$8.86M |
|
$8.86M |
|
$8.86M |
|
0.57M |
|
| Cash Flow Statement Financials | |
$-13.29M |
|
$-0.81M |
|
$-1.87M |
|
$28.86M |
|
$12.90M |
|
$-15.97M |
|
$3.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.97 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.12 |
0.26 |
|
-9.99% |
|
-123.69% |
|
-123.69% |
|
-117.29% |
|
-124.57% |
|
-124.09% |
|
$-14.10M |
|
-- |
|
-- |
|
-- |
|
0.84 |
|
37.57 |
|
12.02 |
|
30.36 |
|
-362.16% |
|
-362.16% |
|
-103.93% |
|
-318.96% |
|
$15.59 |
|
$-24.97 |
|
$-23.54 |
|